

Is Uceris still in shortage in 2026? Get the latest update on Uceris availability, pricing, alternatives, and how to find it in stock near you.
If you rely on Uceris (Budesonide) to manage your ulcerative colitis, you've probably experienced the frustration of showing up at the pharmacy only to be told it's out of stock. This has been an ongoing problem — and many patients want to know: has anything changed in 2026?
Here's the latest on what's happening with Uceris supply, what it costs, and what you can do about it.
The answer depends on which formulation you need:
The FDA has listed Budesonide rectal foam on its shortage database intermittently since 2022. While the situation has improved from its worst point, it hasn't fully resolved.
Several factors continue to drive availability challenges:
The rectal foam is a pressurized aerosol product — not a simple tablet or capsule. Manufacturing requires specialized equipment, strict environmental controls, and complex quality testing. Very few pharmaceutical manufacturers have this capability, so when production issues arise at even one facility, the national supply takes a hit.
Pharmaceutical supply chains have been strained since the COVID-19 pandemic. Raw material sourcing, component shortages (like aerosol canisters and actuators), and shipping logistics all contribute to unpredictable supply. Uceris, as a specialty product with complex packaging, is more vulnerable to these disruptions than a standard oral medication.
Even when Uceris is being produced, it doesn't always end up where patients need it. Large chain pharmacies in high-demand areas may sell through their allocation quickly, while other pharmacies in different regions may have stock sitting on shelves. This uneven distribution creates the experience of a shortage even when total supply might be adequate nationally.
Cost remains a significant concern for Uceris patients:
With insurance, your cost depends on your plan's formulary tier and your deductible status. Many plans place Uceris on Tier 3 (preferred brand) or specialty tier, resulting in copays of $50 to $150+ per fill. Prior authorization and step therapy requirements are common.
If cost is a barrier, read our detailed guide on how to save money on Uceris in 2026.
While no major new Budesonide formulations have launched specifically for UC in 2026, several developments are worth noting:
For a full comparison of alternatives, see our post on alternatives to Uceris.
Here are the most effective strategies for locating Uceris:
Medfinder.com lets you search for pharmacies with Uceris in stock near your zip code. It's the fastest way to check availability without making a dozen phone calls.
Don't limit yourself to your usual chain pharmacy. Independent pharmacies, specialty pharmacies, and mail-order pharmacies may all have stock when the big chains don't. For detailed tips, read our guide on how to find Uceris in stock near you.
If you're on the tablet form, generic Budesonide ER is often more available and costs significantly less. Talk to your doctor about whether switching from brand to generic is appropriate for you.
Start your refill process at least 7-10 days before you run out. If your pharmacy needs to special-order Uceris, having extra lead time prevents gaps in your treatment.
The Uceris shortage has been a long and frustrating experience for UC patients. While the situation is slowly improving — especially for the oral tablet form — the rectal foam remains challenging to find in some areas.
The best thing you can do is stay proactive: use tools like Medfinder, explore all pharmacy options, discuss alternatives with your doctor, and never wait until your last dose to start looking for a refill.
Ulcerative colitis doesn't wait, and neither should you. Take control of your medication access today.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.